✦ LIBER ✦

Non-pegylated liposomal doxorubicin in metastatic breast cancer patients: A valuable therapeutic option requiring caution

✍ Scribed by Daniele Bernardi; Domenico Errante; Micaela Stefani; Luigi Salvagno

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-pegylated liposomal doxorubicin and

✍ Peter Schmid; J. Krocker; R. Kreienberg; P. Klare; K. Kittel; H. Sommer; G. Hein 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 246 KB

Fatal pneumonitis after treatment with p

✍ Michael Mark, Beat Thürlimann 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 121 KB

Metronomic administration of pegylated l

✍ E. Munzone; A. Di Pietro; A. Goldhirsch; I. Minchella; E. Verri; M. Cossu Rocca; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Pegylated liposomal doxorubicin in combi

✍ Alessandra Fabi; Gianluigi Ferretti; Paola Papaldo; Nello Salesi; Mariangela Cic 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 242 KB

PCN6 PRESERVED ANTITUMOR ACTIVITY AND RE

✍ K Mann; C Rana; A Wadhwa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

First line therapy with paclitaxel (Taxo

✍ D.A Vorobiof; B.L Rapoport; M.R Chasen; C Slabber; G McMichael; R Eek; C Mohamme 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 189 KB